Lv7
5000 积分 2022-09-05 加入
Prostate cancer
18天前
已完结
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
1个月前
已完结
XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma
3个月前
已完结
Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program
3个月前
已完结
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
6个月前
已完结
Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis
6个月前
已完结
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–Human Epidermal Growth Factor Receptor 2 Therapy
6个月前
已完结
Artificial Intelligence and Pathomics
7个月前
已完结
Artificial intelligence applications in prostate cancer
7个月前
已完结
皖公网安备34019202002308
